Strides Pharma Consolidates European Business-to-Business Operations in Switzerland

Share
  • Market proximity of Strides Pharma International AG, based in Zug, Switzerland, opens the way for rapid technology transfer and innovation within the European market
  • Oren Weininger, longstanding leader at Fairmed Healthcare, heads the business as CEO and Chairman of the Board
Oren Weininger, CEO Copyright Strides Pharma International AG.
Oren Weininger, CEO Copyright Strides Pharma International AG.

Zug, Switzerland. Strides Pharma Science Limited, globally recognized as a leading pharmaceutical company operating across 100 countries and headquartered in Bangalore, India, is consolidating its European business through Strides Pharma International AG, based in Zug, Switzerland.

Strides Pharma specializes in the development and manufacturing of IP-led niche finished dosage formulations. With over three decades of research and development expertise, Strides Pharma continuously develops and delivers products with innovative and improved technologies at competitive prices. Notably, Strides Pharma is among the world's largest manufacturers of Ibuprofen and Macrogol in various forms. Their unique range of drug delivery technologies opens up versatile and lucrative opportunities within the ever-evolving target markets.

The partner-centric in-licensing portfolio of over 250 formulations is consolidated in synergICE as a one-stop shop. It includes generics, sterile injectables and value-added products, Women´s Health hormones, lyophilized orally dissolving tablets and end-to-end biopharmaceutical CDMO services.

Oren Weininger, newly appointed Chairman of the Board, stated, “With this strengthened European B2B presence, we can respond faster to our customers’ needs and provide flexible, innovative solutions, and interesting generic portfolio, including comprehensive support in supply chain & quality management and regulatory processes by Strides Pharma International and the EU GMP-site in Hamburg, Germany.”

Key Markets are Central and Southern Europe (especially Germany), Scandinavia, Benelux and the Visegrád countries.

For further information, please visit: www.fair-med.com/newsroom

Contact Agency What About Now, Andreas Schöpf
as@whataboutnow.de Tel. +49 160 90723690

Following his roles at Dexcel Pharma and Kamedis, Oren Weininger took the position of CEO at Fairmed Healthcare AG in 2014 and subsequently became owner in 2018. Strides Pharma, after a period of successful partnership, invested in the company in 2019, further bolstering leading Fairmed Healthcare product lines. In addition to being appointed Chairman of the Board of Strides Pharma International AG, Weininger continues to lead Fairmed Healthcare GmbH in Hamburg.

Strides Pharma Science Limited, headquartered in Bangalore, India, was incorporated in 1990. The company has a global manufacturing footprint with eight facilities spread across four continents and a strong presence in 100 countries. Strides Pharma is a key active pharmaceutical ingredient manufacturer and producer of various products; every fourth Ibuprofen tablet on the global market today is supplied by Strides Pharma.

Images

Oren Weininger, CEO Copyright Strides Pharma International AG.
Oren Weininger, CEO Copyright Strides Pharma International AG.
Download

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

OpenCloud 2.0.0 offers enterprise services, support and “File Native Backup”27.3.2025 11:14:39 CET | Press release

Berlin, Germany, March 27, 2025 – Following the successful release of OpenCloud 1.0 in February 2025, OpenCloud now launches its commercial offering including various enterprise service packages for its new solution for file management, file sharing and collaboration. OpenCloud 2.0.0 provides users with long-term software support, fast security updates, checks during update rollouts, high-availability solutions and personal support. OpenCloud can be run in in-house data centers or through selected partners.

ZDF German Television: From historical conflicts to family ties: New8 showcases second slate of international drama series26.3.2025 15:32:26 CET | Press release

Following the success of the first series of New8, the new projects of this international drama collaboration of eight public broadcasters were presented today at Series Mania in Lille. The partners of New8 – SVT (Sweden), DR (Denmark), YLE (Finland), RÚV (Iceland), NRK (Norway), VRT (Flanders, Belgium), NPO (Netherlands) and ZDF (Germany) – have coproduced eight drama series since the start of the collaboration in autumn 2023. The aim of New8 is to coproduce high-quality series across national borders that reflect the values of public service media and appeal to a broad audience.

Weleda AG: Exceptional Partnership: Princess Madeleine and Weleda Launch New Skincare Brand, minLen24.3.2025 13:37:13 CET | Press release

Arlesheim/Stockholm, 24 March 2025 The first natural, responsible multi-generational skincare brand in Europe Princess Madeleine: “Weleda is the ideal partner for developing products that nurture and protect children's natural skin barrier. As a mother, I am mindful about the skincare products my family uses, making minLen a deeply personal project for me.” Weleda CEO Tina Müller: “At a time when even young children are reaching for their mother’s retinol cream, we are introducing an alternative the whole family can use without hesitation. We are honoured to have realised this important project with Madeleine.” First joint public appearance: 28 March 2025, Düsseldorf Weleda AG, the global leader in certified natural skincare and anthroposophic medicines, has partnered with Princess Madeleine – under her private name, Madeleine Bernadotte – to co-develop minLen, a new natural skincare brand. This marks her entry into the beauty industry as an entrepreneur. Through their collaboration, M

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye